Clinical Trial

Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study will enroll patients who have a diagnosis of locally advanced, unresectable or metastatic soft tissue or bone sarcoma (except gastrointestinal stromal tumors and Kaposi's sarcoma) from any site.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2020-11-16; most recent amendment 2026-05-20.
Status change: Recruiting → Active, Not Recruiting 2025-02-19
Status change: Suspended → Recruiting 2024-10-25
Status change: Recruiting → Suspended 2024-10-23
Status change: Not Yet Recruiting → Recruiting 2020-12-18
Trial Details
NCT Number NCT04634227
Lead Sponsor University of Iowa
Collaborators: Mohammed Milhem, MBBS
Conditions Sarcoma, Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma, Metastatic Bone Tumor, Bone Sarcoma
Enrollment 30 participants
Start Date 2020-11-24
Primary Completion 2025-03-18 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-22